[V24-05] Evidence search for the S3 guideline on peri- and postmenopause - diagnostics and interventions
Last updated 27.03.2025
Project no.:
V24-05
Commission:
Commission awarded on 16.05.2024 by the Federal Ministry of Health (BMG).
Report type:
Evidence search
Status:
Commission completed
Department/Division:
Health Care and Guidelines
Topic:
DMP and clinical pratice guidelines
The search for evidence on the S3 guideline on peri- and postmenopause - diagnostics and interventions covers 6 evidence reports.
https://doi.org/10.60584/V24-05A: Cognitive behavioural therapy: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05A)
https://doi.org/10.60584/V24-05B: Isoflavone: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05B)
https://doi.org/10.60584/V24-05C: Cimicifuga: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05C)
https://doi.org/10.60584/V24-05D: SSRI/SSNRI: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05D)
https://doi.org/10.60584/V24-05E: Clonidine: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (24-05E)
https://doi.org/10.60584/V24-05F: Gabapentin: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05F)